Lacto-N-triose II (LNTri II) is a key human milk oligosaccharide (HMO) trisaccharide that serves as a crucial structural precursor in the biosynthesis of more complex HMOs such as lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT). Its unique structure consists of three monosaccharides: N-acetylglucosamine (GlcNAc), galactose (Gal), and glucose (Glc), arranged chemically as GlcNAcβ1,3Galβ1,4Glc.
Structure and Composition
Lacto-N-triose II has the chemical structure GlcNAcβ1,3Galβ1,4Glc, linking the N-acetylglucosamine to galactose via a β1,3 glycosidic bond, and galactose to glucose via a β1,4 bond. This arrangement creates a neutral trisaccharide that functions as a fundamental building block for the formation of larger HMOs abundant in human milk.
Physiological Functions
This trisaccharide plays a significant biological role in infant health. It supports the growth of beneficial gut bacteria such as Bifidobacterium species by serving as a selective prebiotic. Additionally, Lacto-N-triose II contributes to immune system regulation and is associated with the prevention of certain gastrointestinal diseases by promoting a healthy gut microbiota.
Biosynthesis and Production
Biosynthetically, Lacto-N-triose II forms through enzymatic processes involving β-N-acetylhexosaminidases and β-1,3-N-acetylglucosaminyltransferases. Advances in metabolic engineering have enabled microbial production using engineered Escherichia coli, supporting large-scale and sustainable synthesis for potential commercial and nutritional applications.
Safety and Applications
Preclinical evaluations have demonstrated the safety of Lacto-N-triose II for human consumption. This supports its consideration as an ingredient in infant formula and nutritional supplements designed to mimic the beneficial effects of human milk oligosaccharides. Its inclusion can help provide essential oligosaccharides important for optimal gut and immune development, particularly in non-breastfed infants.
In summary, Lacto-N-triose II is a structurally distinct and physiologically important HMO trisaccharide precursor. It plays a central role in infant gut health and immune modulation, with growing potential for industrial production and nutritional supplementation.
